Quantcast
Home > Quotes > CLDX
CLDX

Celldex Therapeutics, Inc. (CLDX) Quote & Summary Data

$2.35
*  
0.08
3.29%
Get CLDX Alerts
*Delayed - data as of Jul. 18, 2019  -  Find a broker to begin trading CLDX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CLDX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 2.35 / $ 2.70
1 Year Target
19
Today's High / Low
$ 2.45 / $ 2.33
Share Volume
137,322
50 Day Avg. Daily Volume
258,400
Previous Close
$ 2.43
52 Week High / Low
$ 11.6187 / $ 2.40
Market Cap
32,356,863
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.34

Intraday Chart

Shares Traded

Share Volume:
137,322
50 Day Avg. Daily Volume:
258,400

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -4.46

Trading Range

The current last sale of $2.35 is -2.08% Lower than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.45 $ 11.6187
 Low: $ 2.33 $ 2.40

Company Description (as filed with the SEC)

Celldex Therapeutics, Inc., which we refer to as "Celldex," "we," "us," "our" or the "Company," is a biopharmaceutical company focused on the development and commercialization of immunotherapies and other targeted biologics. Our drug candidates are derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. They are aimed at addressing market opportunities for which we believe current therapies are inadequate or non-existent.  ... More ...  



Risk Grade

Where does CLDX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.44
Open Date:
Jul. 18, 2019
Close Price:
$ 2.35
Close Date:
Jul. 18, 2019


Consensus Recommendation

Analyst Info